Johnson & Johnson on Jan. 25 forecast as much as $3.5 billion in sales of the company’s COVID-19 vaccine in 2022, a 46% jump for the shot that has fared poorly compared to rivals. Additionally, J&J plans to take a more aggressive stance on deals for the company’s medical device unit.
The U.S. health regulator issued a warning letter to Medtronic Plc highlighting certain concerns related to medical device quality management at its diabetes business, the company said on December 15.
Carmat on December 3 said the French medical device company suspended implants of the Aeson artificial hearts following a quality issue affecting some of its prostheses.
Johnson & Johnson on Oct. 19 reported lower-than-expected quarterly revenue after sales of the company’s Covid-19 vaccine missed Wall Street estimates following a string of production setbacks.
High Point, North Carolina-based vTv Therapeutics announced positive results from a mechanistic study of TTP399 in type 1 diabetes patients.
Boston Scientific entered into a deal to acquire Baylis Medical, a medical devices maker with headquarters in Canada, for an upfront payment of $1.75 billion in a bid to expand the Mass.-based company’s electrophysiology and structural heart product portfolio.
Thermo Fisher Scientific’s clinical sequencing business and AstraZeneca announced they will co-develop next-generation sequencing (NGS)-based companion diagnostics (CDx) to support AstraZeneca’s expanding portfolio of targeted therapies.
A federal appeals court on Aug. 16 revived nearly 6,000 lawsuits alleging that a widely used device produced by 3M Co. to keep surgical patients warm caused them to develop infections.
The U.S. Food and Drug Administration approved Abbott’s Amplatzer Amulet Left Atrial Appendage Occluder to treat people with atrial fibrillation (AFib) who are at risk of ischemic stroke.
Scientists from the University of California, San Francisco have developed a tool that would give paralyzed persons who are unable to speak the ability to communicate through text that appears on a screen.
